Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Waystar Holding Corp. (WAY) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Health Information Services
$23.03
+0.60 (2.67%)Did WAY Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Waystar is one of their latest high-conviction picks.
Based on our analysis of 3 Wall Street analysts, WAY has a bullish consensus with a median price target of $33.00 (ranging from $25.00 to $44.00). The overall analyst rating is Strong Buy (9.4/10). Currently trading at $23.03, the median forecast implies a 43.3% upside. This outlook is supported by 23 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for WAY.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 2, 2026 | Keybanc | Scott Schoenhaus | Overweight | Initiates | $30.00 |
| May 20, 2026 | Barclays | Overweight | Maintains | $N/A | |
| May 5, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Apr 30, 2026 | JP Morgan | Overweight | Maintains | $N/A | |
| Apr 30, 2026 | UBS | Buy | Maintains | $N/A | |
| Apr 30, 2026 | Needham | Buy | Reiterates | $N/A | |
| Apr 10, 2026 | B of A Securities | Buy | Maintains | $N/A | |
| Mar 30, 2026 | Morgan Stanley | Equal-Weight | Initiates | $N/A | |
| Mar 12, 2026 | Deutsche Bank | Buy | Maintains | $N/A | |
| Feb 19, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Feb 18, 2026 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Feb 18, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Feb 18, 2026 | BMO Capital | Outperform | Maintains | $N/A | |
| Feb 18, 2026 | Goldman Sachs | Buy | Maintains | $N/A | |
| Feb 18, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Feb 18, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Feb 18, 2026 | Evercore ISI Group | Outperform | Maintains | $N/A | |
| Feb 18, 2026 | Freedom Capital Markets | Buy | Upgrade | $N/A | |
| Feb 17, 2026 | Needham | Buy | Maintains | $N/A | |
| Jan 9, 2026 | Citigroup | Buy | Maintains | $N/A |
The following stocks are similar to Waystar based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Waystar Holding Corp. has a market capitalization of $4.42B with a P/E ratio of 34.4x. The company generates $1.16B in trailing twelve-month revenue with a 10.9% profit margin.
Revenue growth is +22.4% quarter-over-quarter, while maintaining an operating margin of +25.6% and return on equity of +3.6%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides cloud-based healthcare payment solutions.
Waystar generates revenue by offering a comprehensive cloud-based platform that automates and streamlines healthcare payment processes for providers. The company charges healthcare organizations, such as hospitals and surgery centers, for using its software solutions, which include features like AI-powered automation, financial clearance, and revenue cycle management.
Founded in 2017 and based in Lehi, Utah, Waystar serves over one million healthcare providers across the country. Its platform integrates with electronic health records and utilizes advanced AI technologies to enhance efficiency and billing accuracy. The company's commitment to integrity and innovation positions it as a key player in the health information services industry, helping clients improve financial performance and patient experiences.
Healthcare
Health Information Services
1,700
Mr. Matthew J. Hawkins
United States
2024
Waystar (WAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Waystar (WAY) saw a rise in share price with above-average trading volume, but recent earnings estimate revisions indicate potential weakness ahead.
Waystar's share price surge with high trading volume indicates short-term interest, but stagnant earnings estimates suggest potential long-term weakness, signaling caution for future investments.
Waystar Holding Corp. (Nasdaq: WAY) will hold an Investor Day on August 25, 2026, in San Antonio, Texas, starting at 1:00 p.m.
Waystar's Investor Day signals a platform for strategic updates and potential growth insights, influencing investor sentiment and stock valuation.
Waystar Holding Corp. is rated a buy with an 85% upside to a $37 target. Revenue grew 22% YoY, with strong profit margins. Analysts favor the stock, citing growth drivers like acquisitions and AI solutions.
Waystar's strong growth, high profit margins, and analyst support indicate solid fundamentals, while the stock's current price reflects temporary selling pressure, presenting a potential buying opportunity.
Waystar's report reveals healthcare leaders favor a unified AI platform for revenue cycle management, yet 86% are not fully optimizing revenue opportunities.
The unanimous interest in AI-powered platforms highlights a significant market opportunity in healthcare revenue cycle management, indicating potential growth for companies like Waystar.
In Q1 2026, Baron Discovery Fund's Institutional Shares fell 10.65%, underperforming the Russell 2000 Growth Index by 7.84%. The fund sold its stake in Intapp, Inc. while Advanced Energy Industries, Inc. saw stock gains.
The decline of the Baron Discovery Fund signals potential risks in the software sector, while Advanced Energy's growth highlights opportunities in data centers and semiconductors.
WAY's AI-driven revenue cycle management (RCM) growth and strong Q1 results are notable. TruBridge's stock is trading close to its buyout price, suggesting limited upside potential.
WAY's strong Q1 results indicate robust growth potential, attracting investor interest. TruBridge's stagnant price suggests limited investment opportunities ahead.
Based on our analysis of 3 Wall Street analysts, Waystar Holding Corp. (WAY) has a median price target of $33.00. The highest price target is $44.00 and the lowest is $25.00.
According to current analyst ratings, WAY has 23 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $23.03. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict WAY stock could reach $33.00 in the next 12 months. This represents a 43.3% increase from the current price of $23.03. Please note that this is a projection by Wall Street analysts and not a guarantee.
Waystar generates revenue by offering a comprehensive cloud-based platform that automates and streamlines healthcare payment processes for providers. The company charges healthcare organizations, such as hospitals and surgery centers, for using its software solutions, which include features like AI-powered automation, financial clearance, and revenue cycle management.
The highest price target for WAY is $44.00 from at , which represents a 91.1% increase from the current price of $23.03.
The lowest price target for WAY is $25.00 from at , which represents a 8.6% increase from the current price of $23.03.
The overall analyst consensus for WAY is bullish. Out of 3 Wall Street analysts, 23 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $33.00.
Stock price projections, including those for Waystar Holding Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.